Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Merck
Merck
Page 3 of 9
Health
Merck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill
By
John Lauerman
and
Bloomberg
November 9, 2021
Health
Pfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward
By
Contributing Writer
November 5, 2021
Health
Merck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
By
Frank Connelly
and
Bloomberg
November 4, 2021
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By
Industry Analyst
October 27, 2021
Health
Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again
By
James Paton
and
Bloomberg
October 12, 2021
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By
Matthew Perrone
and
The Associated Press
October 11, 2021
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By
Thomas Mulier
,
Riley Griffin
and
Bloomberg
October 8, 2021
Health
Everything to know about Merck’s COVID antiviral pill
By
Staff Writer
October 5, 2021
Health
Shares of vaccine makers slump as Merck unveils data from its ‘game-changer’ COVID pill
By
Abhishek Vishnoi
and
Bloomberg
October 4, 2021
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By
Matthew Perrone
and
The Associated Press
October 1, 2021
Health
The psychology behind why people will take horse paste, but not COVID vaccines
By
Blockchain Reporter
September 2, 2021
Health
Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world
By
Research Team
September 2, 2021
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By
Financial Writer
August 5, 2021
Tech
IBM, Merck and OneTen launch network to recruit and promote Black workers over the next decade
By
Jeff Green
and
Bloomberg
June 29, 2021
Health
Merck takes huge hit for its abandoned COVID-19 drug efforts
By
Riley Griffin
and
Bloomberg
May 6, 2021
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Crypto Correspondent
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Contributing Writer
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Editorial Team